|
| Jian Jin | FIRC Institute of Molecular Oncology, University of Basel, ETH Zurich, European Institute of Oncology, Uppsala University, The Francis Crick Institute, United Kingdom Center for Chemical Biology and Drug Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Milan |
| Richard Mitter | FIRC Institute of Molecular Oncology, University of Basel, ETH Zurich, European Institute of Oncology, Uppsala University, The Francis Crick Institute, United Kingdom Center for Chemical Biology and Drug Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Milan |
| Diego Pasini | FIRC Institute of Molecular Oncology, University of Basel, ETH Zurich, European Institute of Oncology, Uppsala University, The Francis Crick Institute, United Kingdom Center for Chemical Biology and Drug Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Milan |